New Year Bumper Sale @ Rs. 1 X
Carvistar 12.5 Tablet is a prescription drug, available for use as Tablet. High BP are some of its major therapeutic uses. The alternative uses of Carvistar 12.5 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Carvistar 12.5 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Carvistar 12.5 Tablet as well, which are listed below. Usually, these side effects of Carvistar 12.5 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Carvistar 12.5 Tablet is Moderate for pregnant women and Safe for women who are breastfeeding. In addition, Carvistar 12.5 Tablet's effects on the liver, heart and kidney are discussed below in the Carvistar 12.5 Tablet related warnings section.
Carvistar 12.5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Carvistar 12.5 Tablet in conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD). Other contraindications of Carvistar 12.5 Tablet have been discussed in the sections ahead.
Drug reaction of Carvistar 12.5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Carvistar 12.5 Tablet is not safe while driving, and is is not addictive in nature.
Carvistar 12.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Carvistar 12.5 Tablet is used -
Severe
Moderate
Mild
Is the use of Carvistar 12.5 Tablet safe for pregnant women?
Carvistar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Carvistar right away. Take your doctor's advice before taking it again.
Is the use of Carvistar 12.5 Tablet safe during breastfeeding?
Carvistar is completely safe for breastfeeding women.
What is the effect of Carvistar 12.5 Tablet on the Kidneys?
Carvistar is completely safe for kidneys.
What is the effect of Carvistar 12.5 Tablet on the Liver?
Carvistar may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Carvistar 12.5 Tablet on the Heart?
Side effects of Carvistar rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Carvistar 12.5 Tablet unless your doctor advises you to do so -
Is this Carvistar 12.5 Tablet habit forming or addictive?
Carvistar 12.5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Carvistar 12.5 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Carvistar 12.5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Carvistar 12.5 Tablet in mental disorders is not effective.
Interaction between Food and Carvistar 12.5 Tablet
Carvistar 12.5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Carvistar 12.5 Tablet
Consumption of alcohol and Carvistar 12.5 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)